Hemington Wealth Management Argenx Se Call Options Transaction History
Hemington Wealth Management
- $769 Million
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ARGX
# of Institutions
496Shares Held
28.1MCall Options Held
370KPut Options Held
211K-
Price T Rowe Associates Inc Baltimore, MD4.98MShares$4.11 Billion0.31% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.79MShares$2.3 Billion2.84% of portfolio
-
Janus Henderson Group PLC London, X02.57MShares$2.12 Billion0.73% of portfolio
-
Capital World Investors Los Angeles, CA1.95MShares$1.61 Billion0.16% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.18MShares$971 Million11.81% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $45.7B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...